Market Overview:
The global dorzolamide hydrochloride market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of glaucoma, rising awareness about glaucoma and its treatment options, and the growing geriatric population. By type, the on-line segment is expected to account for the largest share of the global dorzolamide hydrochloride market in 2018, followed by hospital and drug store segments. By application, pregnancy segment is expected to account for the largest share of the global dorzolamide hydrochloride market in 2018, followed by pediatric use and geriatric use segments.
Product Definition:
Dorzolamide hydrochloride is a carbonic anhydrase inhibitor used to treat glaucoma. It decreases the production of aqueous humor and thereby lowers intraocular pressure.
On-Line:
On-line is a method of producing HCl by the hydrolysis of chlorobenzene. It is also used as an intermediate in the production of other chemicals such as 1,4 butanediol (BDO), which can be further processed to produce polymers and resins. On-line methods are usually preferred over conventional methods owing to their high productivity and lower operating costs.
Hospital:
A hospital is a facility where patients are admitted and receive treatment. It is also used to provide care for recovered patients. Hospitals can be classified on the basis of their specialty as general hospitals, psychiatric hospitals, rehabilitation centers, cancer hospitals & clinics and other specialty or subspecialty hospitals such as burn centers, heart disease & cardiac surgery institutes etc.
Application Insights:
Pregnancy was the largest application segment in 2017 and is expected to grow at a CAGR of XX% from 2018 to 2030. The product is used for the treatment of glaucoma, open-angle glaucoma, ocular hypertension and urinary retention in pregnancy. It has been found safe for use during lactation as well as pediatric usage; hence, dorzolamide hydrochloride is anticipated to be one of the lucrative segments during the forecast period.
The geriatric population suffers from various eye diseases such as glaucoma and myopia (near-sightedness). Dorzolamide Hydrochloride (DOZ) 0.5%/6ml can be used for treating these eye diseases due to its ability to reduce intraocular pressure by decreasing fluid retention in eyesocket.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors contributing to its growth. In addition, growing awareness about osteoporosis treatment options is expected to drive demand for dorzolamide hydrochloride tablets in this region.
Asia Pacific is anticipated to witness fastest growth during the forecast period owing to rising disposable income levels and improving healthcare infrastructure coupled with an increase in consumer awareness regarding osteoporosis treatment options over time.
Growth Factors:
- Increasing prevalence of glaucoma: The number of people affected by glaucoma is increasing globally. This will drive the demand for Dorzolamide Hydrochloride as it is the only drug approved for the treatment of open-angle glaucoma.
- Growing awareness about glaucoma and its treatment options: There is a growing awareness among people about glaucoma and its various treatment options including Dorzolamide Hydrochloride. This will help to increase the demand for this drug in the coming years.
- Rising incidence of eye injuries: The incidence of eye injuries is rising globally due to increasing violence and accidents. This is leading to an increase in the number of people requiring treatment for ocular hypertension or open-angle glaucoma, which can be treated with Dorzolamide Hydrochloride drugs like Trusopt® 2%.
- Technological advancements in ophthalmology: There have been several technological advancements in ophthalmology over the past few years, such as femtosecond laser-assisted cataract surgery, which has helped improve outcomes for patients with Glaucoma .This will lead to an increased use of Dorzolamide Hydrochloride drugs like Trusopt® 2%in future surgeries . 5) Availabilityof generic versionsofDorzolamidedrugs: A number oftgeneric versionsofDorzomidemdrugs are available
Scope Of The Report
Report Attributes
Report Details
Report Title
Dorzolamide Hydrochloride Market Research Report
By Type
On-Line, Hospital, Drug Store
By Application
Pregnancy, Lactation, Pediatric Use, Geriatric Use
By Companies
Alembic Pharms, Bausch and Lomb, FDC, Hi Tech Pharma, Micro Labs, Novartis, Merck, Purdue Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Dorzolamide Hydrochloride Market Report Segments:
The global Dorzolamide Hydrochloride market is segmented on the basis of:
Types
On-Line, Hospital, Drug Store
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pregnancy, Lactation, Pediatric Use, Geriatric Use
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alembic Pharms
- Bausch and Lomb
- FDC
- Hi Tech Pharma
- Micro Labs
- Novartis
- Merck
- Purdue Pharma
Highlights of The Dorzolamide Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- On-Line
- Hospital
- Drug Store
- By Application:
- Pregnancy
- Lactation
- Pediatric Use
- Geriatric Use
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dorzolamide Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dorzolamide hydrochloride is a medication used to relieve pain from various conditions, such as migraine headaches, toothache, and menstrual cramps. It works by blocking nerve impulses that cause pain.
Some of the major companies in the dorzolamide hydrochloride market are Alembic Pharms, Bausch and Lomb, FDC, Hi Tech Pharma, Micro Labs, Novartis, Merck, Purdue Pharma.
The dorzolamide hydrochloride market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dorzolamide Hydrochloride Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dorzolamide Hydrochloride Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dorzolamide Hydrochloride Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dorzolamide Hydrochloride Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dorzolamide Hydrochloride Market Size & Forecast, 2018-2028
4.5.1 Dorzolamide Hydrochloride Market Size and Y-o-Y Growth
4.5.2 Dorzolamide Hydrochloride Market Absolute $ Opportunity
Chapter 5 Global Dorzolamide Hydrochloride Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Dorzolamide Hydrochloride Market Size Forecast by Type
5.2.1 On-Line
5.2.2 Hospital
5.2.3 Drug Store
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Dorzolamide Hydrochloride Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Dorzolamide Hydrochloride Market Size Forecast by Applications
6.2.1 Pregnancy
6.2.2 Lactation
6.2.3 Pediatric Use
6.2.4 Geriatric Use
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dorzolamide Hydrochloride Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dorzolamide Hydrochloride Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Dorzolamide Hydrochloride Analysis and Forecast
9.1 Introduction
9.2 North America Dorzolamide Hydrochloride Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Dorzolamide Hydrochloride Market Size Forecast by Type
9.6.1 On-Line
9.6.2 Hospital
9.6.3 Drug Store
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Dorzolamide Hydrochloride Market Size Forecast by Applications
9.10.1 Pregnancy
9.10.2 Lactation
9.10.3 Pediatric Use
9.10.4 Geriatric Use
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Dorzolamide Hydrochloride Analysis and Forecast
10.1 Introduction
10.2 Europe Dorzolamide Hydrochloride Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Dorzolamide Hydrochloride Market Size Forecast by Type
10.6.1 On-Line
10.6.2 Hospital
10.6.3 Drug Store
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Dorzolamide Hydrochloride Market Size Forecast by Applications
10.10.1 Pregnancy
10.10.2 Lactation
10.10.3 Pediatric Use
10.10.4 Geriatric Use
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Dorzolamide Hydrochloride Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Dorzolamide Hydrochloride Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Dorzolamide Hydrochloride Market Size Forecast by Type
11.6.1 On-Line
11.6.2 Hospital
11.6.3 Drug Store
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Dorzolamide Hydrochloride Market Size Forecast by Applications
11.10.1 Pregnancy
11.10.2 Lactation
11.10.3 Pediatric Use
11.10.4 Geriatric Use
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Dorzolamide Hydrochloride Analysis and Forecast
12.1 Introduction
12.2 Latin America Dorzolamide Hydrochloride Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Dorzolamide Hydrochloride Market Size Forecast by Type
12.6.1 On-Line
12.6.2 Hospital
12.6.3 Drug Store
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Dorzolamide Hydrochloride Market Size Forecast by Applications
12.10.1 Pregnancy
12.10.2 Lactation
12.10.3 Pediatric Use
12.10.4 Geriatric Use
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Dorzolamide Hydrochloride Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Dorzolamide Hydrochloride Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Dorzolamide Hydrochloride Market Size Forecast by Type
13.6.1 On-Line
13.6.2 Hospital
13.6.3 Drug Store
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Dorzolamide Hydrochloride Market Size Forecast by Applications
13.10.1 Pregnancy
13.10.2 Lactation
13.10.3 Pediatric Use
13.10.4 Geriatric Use
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dorzolamide Hydrochloride Market: Competitive Dashboard
14.2 Global Dorzolamide Hydrochloride Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alembic Pharms
14.3.2 Bausch and Lomb
14.3.3 FDC
14.3.4 Hi Tech Pharma
14.3.5 Micro Labs
14.3.6 Novartis
14.3.7 Merck
14.3.8 Purdue Pharma
